Endoscopic Resection and Topical 5-Fluorouracil as an Alternative Treatment to Craniofacial Resection for the Management of Primary Intestinal-Type Sinonasal Adenocarcinoma by Mackie, Simon et al.
Hindawi Publishing Corporation
Minimally Invasive Surgery




5-Fluorouracil as an Alternative Treatment to
Craniofacial Resection for the Management of Primary
Intestinal-Type Sinonasal Adenocarcinoma
Simon Mackie,1 Tass Malik,2 andHishamKhalil2
1Peninsula Medical School, Derriford Hospital, Plymouth, PL6 8DH, UK
2Department of Otolaryngology, Derriford Hospital, Plymouth, PL6 8DH, UK
Correspondence should be addressed to Simon Mackie, simon.mackie@students.pms.ac.uk
Received 11 August 2010; Revised 3 December 2010; Accepted 28 December 2010
Academic Editor: Casey M. Calkins
Copyright © 2010 Simon Mackie et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction. Intestinal-type adenocarcinoma of the sinonasal tract is very rare and is responsible for less than 4% of tumours
of the sinuses. Craniofacial resection has been the mainstay of treatment for many years; however, techniques for endoscopic
resection are constantly being developed. Discussion. The use of transnasal endoscopic resection (TER) and topical chemotherapy
applications as an alternative to cranio-facial resection (CFR) is discussed. TER oﬀers advantages over CFR in terms of fewer intra-
operative complications and an improved cosmetic outcome. Survival and metastatic rates are similar between both procedures.
Patients with locally invasive tumours are better managed with CFR. Topical applications of 5-Fluorouracil has been shown to be
eﬀective in increasing survival in patients with sino-nasal malignancy. Conclusion. Trans-nasal endoscopic resection and topical
5-Fluorouracil could potentially oﬀer an acceptable alternative treatment to the standard of cranio-facial resection. This should be
investigated in trials with a longer followup period than this paper in order to directly compare the two treatment modalities.
1.Introduction
Adenocarcinoma of the paranasal sinuses is rare and gen-
erally follows an aggressive clinical course [1]. Craniofacial
resection has been the mainstay of treatment for many years
now and represents the gold standard of surgical resection.
However, endoscopic techniques for resection are constantly
being developed and may represent a viable alternative with
fewer complications. As well as this, chemotherapy and
radiotherapy are important treatment options and can be
used to augment the eﬀects of surgery [2].
In this paper, a patient with sinonasal adenocarcinoma
treated by endoscopic resection is presented.
2.CaseReport
A 66-year-old woman presented for biopsy of the left
ethmoid sinus and nasal cavity in order to assess possi-
ble recurrence of ethmoidal adenocarcinoma. The patient
was initially referred 3 years ago to the Ear Nose and
Throat (ENT) Department by her G.P. after she experienced
continual unilateral left facial pain. On biopsy of the left
ethmoid sinus, there was shown to be an intestinal type
adenocarcinoma. MRI imaging of the face/neck and CT of
the thorax and abdomen displayed that the malignancy was
conﬁned to the left paranasal sinuses (Figure 1).
Despite being oﬀered a craniofacial resection (CFR),
for cosmetic reasons, the patient elected for endoscopic
removalofthetumour,whichwascarriedoutinAugust2006
(Figure 2).However,thepatientcontinuedtoexperienceleft-
sided dull facial pain, and on biopsy a recurrence of the
tumourwasfound(Figure 3).Thiswastreatedwithafurther
endoscopic resection.
Following this, regular biopsies were taken, and residual
disease following the revision endoscopic resection was
treated with 5-Fluorouracil topical chemotherapy. Topical2 Minimally Invasive Surgery
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Figure 1: CT scans taken in 2006 after the patient’s initial referral to ENT. (a) CT scan showing a mass in the left nasal cavity, and (b) CT
scan showing the mass in the left ethmoid sinus, The mass was initially thought to be an inverted papilloma, but following histology it was
shown to be an intestinal-type adenocarcinoma.
Figure 2: CT scan taken in 2007 showing evidence of surgery in
the patient’s left nasal cavity. The lesion has been removed, and the
maxillary ostium is widened.
chemotherapy was again used in September 2008 to treat a
recurrence of the tumour, located in the posterior ethmoidal
sinus.
The patient has continued to experience dull left-sided




A review of the literature was carried out using databases
such as Medline, Embase, and the Cochrane Library. The
references of review articles were also used.
3.1. Craniofacial Resection. Craniofacial resection (CFR) was
ﬁrst described in 1963 and has since been considered the
standard treatment for malignancies involving the anterior
skull base [2, 3]. Whilst CFR has been shown to have low
recurrence rates, it is also associated with a long recovery and
complication rates as high as 40% in some studies [2].
3.2. Is Endoscopic Resection a Viable Alternative? Endoscopic
resection as a technique to remove malignant anterior skull
base lesions has always been controversial, with many argu-
ing that it is not safe. However, in the light of recent advances
in both technology and equipment, techniques are now
available which allow this resection to be carried out safely.
Transnasal endoscopic resection (TER) is a procedure that
many now believe to be a reasonable alternative to CFR [2].
Several studies have aimed to compare the eﬀects of
both CFR and TER. Eloy et al. performed a retrospective
analysisinFloridawhichfoundthattherewerenosigniﬁcant
diﬀerences in complication rate, postoperative survival, or
metastasis between the two procedures. Moreover, it found
that hospital stays were signiﬁcantly shorter in the TER
group of patients. Finally, improved cosmetic outcome was
foundwithendoscopic resection.Thisisanimportantaspect
for many patients, and TER can completely eliminate the
need for external incisions and therefore scars [2]. This view
that TER is safe and advantageous is found in many studies
[2, 4–6].
TERalsoholdsadvantagesintraoperatively.Theexcellent
visualisation oﬀered by the endoscope could result in a
safer and more precise procedure. Podboj and Smid. found
that operating time was on average an hour shorter, and
blood loss during surgery was less than half of that with
traditional external approaches. As well as this, postoperative
radiotherapy, which may be delayed by wound healing with
CFR, can be administered immediately following TER [5].Minimally Invasive Surgery 3
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Figure 3: (a) CT scan taken in 2007 showing soft tissue with bony wall destruction in the patient’s left posterior ethmoid sinus, which was
a recurrence of the malignancy and treated with topical chemotherapy. (b) MRI scan taken in 2008 showing an area of high signal in the
patient’s left maxillary antrum, indicating the need for a biopsy to be performed.
Endoscopic resection for sinonasal tumours is reported
to be a demanding procedure. Several papers support the
view that it is a safe technique in the hands of a skilled and
experienced surgeon [2, 5]. Aside from this patient, selection
is an important issue. Patients with tumours invading the
orbit, skin, or lateral recess of the frontal sinus are better
managed with conventional CFR [4].
One potential problem with TER is the eﬀect on
surgical excision margins. This approach usually results in a
piecemeal resection approach, and this means that normal
histopathological methods of measuring excision margins
may not be possible. As a result of this, it is suggested that
samples for frozen section are to be taken during the surgery
to be analysed postoperatively [5]. As well as this, inadequate
resection margins may make recurrence more likely, and it
is suggested that this is more common with an endoscopic
approach [7].
Recurrence of the malignancy postoperatively for both
endoscopic and traditional methods has been measured in
several studies. Recurrence is the primary cause of cancer-
related death in patients with ethmoidal malignancies and
therefore is an important aspect of any treatment [8]. One
recent study found no signiﬁcant diﬀerence between the
methods in terms of metastatic and 5-year survival rates.
There was a slight increase in survival with endoscopy;
however, one explanation for this was the higher rate of
advanced cancers treated with CFR as opposed to TER [2].
Aside from this, the increased visualisation made possible by
utilizing endoscopy, as opposed to the limited visualisation
with CFR, could also be responsible for this slight diﬀerence
and represents a possible signiﬁcant advantage of TER.
Complications are associated with both CFR and TER
techniques. Complications involving the central nervous
system such as Cerebral-Spinal Fluid leaks and pneumo-
cephalus can be encountered in both procedures. However,
the lack of brain retraction with an endoscopic approach
reduces the possibility of brain contusion and edema, which
Table 1: Key advantages and disadvantages of transnasal endo-
scopic resection.
Advantages
(i) Better cosmetic outcome
(ii) Shorter operating time
(iii) Shorter hospital stay
(iv) No delay in postoperative radiotherapy
Disadvantages
(i) Must be performed by a highly skilled and experienced
surgeon
(ii) Not suitable for patients with local invasion or advanced
malignancies
(iii) Diﬃculty determining surgical excision margins
can occur with CFR [4]. Nevertheless, studies which have
directly compared the procedures found no diﬀerence in
complication rates, with the one possible diﬀerence being
increased blood loss with CFR [2].
Aside from pure endoscopic resection, endoscopic-
assisted CFR has gained acceptance as a standard procedure
for management of sinonasal malignancies. This approach
allows for a combined transfacial and transnasal technique,
resulting in a single external incision. This also avoids the
limited working angle which is possible with an endoscopic
transnasal approach alone. A combined technique may
broaden the cases for which endoscopy is suitable [5, 7].
Table 1 displays an overview of the key advantages and
disadvantages of a Transnasal Endoscopic Approach.
3.3. The Role of 5-Fluorouracil. 5-Fluorouracil is an an-
timetabolite and can be used to treat a variety of cancers,
including head and neck cancers. It can be used both4 Minimally Invasive Surgery
intravenously and topically. Toxicity is unusual, with myelo-
suppression and cerebellar syndromes being rare compli-
cations. Its use in sinonasal malignancy is usually topical
following surgery, and this along with other forms of topical
chemotherapy are recognised forms of treatment [9, 10].
A large trial in Rotterdam aimed to assess whether a
traditional CFR approach was superior to surgical debulking
followedbytheapplicationoftopicalchemotherapy.Survival
r a t e sw e r em e a s u r e do v e ra2 3y e a rp e r i o du s i n gt h e
Kaplan-Meier method and a signiﬁcant increase in survival
was found in patients treated with debulking and topical
chemotherapy. It suggests that this method becomes the
mainstay of treatment for sinonasal malignancy [9].
A further study in the UK directly compared survival
rates between 5-Fluorouracil chemotherapy and traditional
methods of radiotherapy and CFR. It found that the survival
rates of 50% with these traditional methods improved to
86% with initial surgical intervention followed by topical
chemotherapy. This is a signiﬁcant diﬀerence and supports
the view that topical 5-Fluorouracil treatments following
surgery become standard for the management of sinonasal
malignancy [11].
4. Conclusions
Transnasal endoscopic resection could represent an accept-
able treatment for patients with sinonasal malignancy that
decline the gold standard treatment of craniofacial resection.
It is gaining a reputation as a safe and eﬀective treatment.
Topical chemotherapy has been shown to increase survival
when combined with debulking surgery and is also an
eﬀective treatment option.
It must also be remembered that TER is not acceptable
forpatientswithlocallyinvadingtumours,andpatientsmust
be selected carefully. Further trials should be undertaken to
directly compare these treatment modalities. Although this
case report supports positive outcomes up to fouryears post-
operation emphasis should be placed on long-term followup
of patients in order to allow further comparison.
5. Summary
What is already known on this topic is the following:
(i) craniofacial resection is the standard of treatment for
sinonasal Malignancies;
(ii) endoscopic resection has always been controversial.
What this paper adds on the topic is the following:
(i) transnasal endoscopic resection could represent an
acceptable treatment for patients who decline a
craniofacial resection;
(ii) the addition of topical chemotherapy to endoscopic
resection can improve survival;
(iii) further trials including long-term followup directly
comparing the two treatment modalities are
required.
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